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Abstract 
Objectives: To determine the relationship between long-term prostate cancer survivors’ symptom burden 
and information needs.  
Subjects/patients and methods: We used population-based data from the Michigan Prostate Cancer Survivor 
Study (n=2,499). We examined unadjusted differences in long-term information needs according to 
symptom burden and performed multivariable logistic regression to examine symptom burden and 
information needs adjusting for patient characteristics.  
Results: High symptom burden was reported across all domains (sexual 44.4%, urinary 14.4%, vitality 
12.7%, bowel 8.4%, emotional 7.6%) with over half of respondents (56%) reporting they needed more 
information. Top information needs involved recurrence, relationships, and long-term effects. Prostate 
cancer survivors with high symptom burden more often searched for information regardless of domain 
(p<0.05). High sexual burden was associated with greater need for information about relationships 
(OR=2.05; 95% CI 1.54-2.72) and long-term effects (OR=1.60; 95% CI 1.23-2.07). High bowel burden was 
associated with greater information need for long-term effects (OR=2.28; 95% CI 1.43-3.63).  
Conclusions: Long-term prostate cancer survivors with high symptom burden need more supportive 
information. Tailoring information to these needs may be an efficient approach to support the growing 
population of long-term prostate cancer survivors.  
 
Introduction 
 There are more than one million new prostate cancer diagnoses each year 
resulting in millions of prostate cancer survivors around the globe (1, 2) with reduced 
quality of life due to treatment-related symptoms. (3-5) Treatment type and satisfaction 
with treatment have distinct impacts on quality of life domains (e.g., urinary, sexual, 
bowel, emotional, vitality). (4) In addition, prostate cancer survivors may be “lost in 
transition” between active treatment and survivorship care leaving them vulnerable to 
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increase, the lack of consensus as to who is responsible for follow-up care (primary 
care clinicians, urologists) increases the risk of persistent symptom burden. (7-10)  
Plans for improved survivorship care are being developed and implemented, 
including the recent American Cancer Society guidelines for prostate cancer 
survivorship care. (11) These guidelines can support primary care clinicians in providing 
long-term prostate cancer survivorship care. However, even when prostate cancer 
symptom burden is high, men may still not report urinary complaints and sexual 
dysfunction to their primary or specialty care clinicians. In some cases, clinicians may 
feel uncomfortable or ill equipped to handle these sensitive topics. (12, 13) As such, 
prostate cancer survivors may engage in symptom self-management by seeking health 
information, and then, caring for themselves. For cancer patients in general, having the 
appropriate amount of cancer-relevant information from a variety of sources improves 
patient outcomes across the cancer control continuum. (14, 15) Information not only 
improves shared decision-making about treatment, (16, 17) but aids in coping and 
reducing stress (15, 18, 19) and may improve overall satisfaction with treatment 
outcomes. (20)  
There are differing information needs and seeking behaviors throughout the 
trajectory of treatment and survivorship for men with prostate cancer. (21) Most studies 
examine information needs immediately after treatment and during the initial years of 
survivorship rather than examining needs later in the survivorship experience when 
many men may continue to struggle with symptoms. Due to the natural history of 
prostate cancer, survivors are likely to need ongoing supportive care and information 
when it comes to treatment side effects and symptom management. (12, 22, 23) (24-26) 
Moreover, evidence suggests that tailoring cancer-specific and self-management 
information to the stage of cancer control continuum (e.g., diagnosis, treatment, post-
treatment) most appropriately meets survivors’ needs. (14) The additional benefit of 
extending this tailored information paradigm to a prostate cancer survivor’s long-term 
symptom burden is under studied, and better understanding the relationship between 
symptom burden and information needs may help identify the most efficient ways to 
support the growing population of prostate cancer survivors (i.e., focusing on those with 
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The objective of this study was to determine if survivors’ domain-specific 
symptom burden was associated with increased long-term information needs. We also 
sought to determine additional patient characteristics (e.g., race, treatment type) that 
may be associated with increased information needs. This analysis focused on 
symptom burden and information needs for two reasons. First, long-term symptom 
burden is a documented problem in prostate cancer survivors, many of whom do not 
seek care for their symptoms. (12) Second, data suggest that prostate cancer survivors 
need more information about a variety of topics, including symptom management and 
coping. (12, 22, 23) Individualized approaches are not typically feasible in health care 
systems due to resource constraints. As such, our analysis identified factors (e.g., high 
sexual burden) to consider for more efficient information tailoring (e.g., relationship 
advice).  
Subjects/patients and methods 
Study population 
 We used data from the Michigan Prostate Cancer Survivor Study, a statewide 
survey of long-term prostate cancer survivor outcomes (see original study for detailed 
methods). (12) Individuals diagnosed with prostate cancer in Michigan between 1985 
and 2004 and alive as of December 31, 2005 were identified from the Michigan Cancer 
Registry. Stratified random sampling was conducted to ensure adequate inclusion of 
prostate cancer survivors based on race/ethnicity, residence (urban versus rural), and 
number of years since diagnosis. African Americans were oversampled due to their 
increased prostate cancer risks. Exclusion criteria included: unconfirmed cancer, 
incarceration, inability to locate, non-resident of Michigan, unable to complete the 
survey, and physician recommendation against patient contact. Surveys were mailed to 
eligible participants (n=6,531), and to maximize response rates, up to two follow-up 
surveys (every six weeks) were mailed to non-respondents. Our final response rate was 
38.3% (2,499 surveys completed). Demographic and treatment factors (age, race, 
marital status, income, education level, years since diagnosis, treatment type, and 
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 To measure prostate cancer survivors’ symptom burden, we focused on 
responses to a single domain-specific survey item that captured burden over the prior 
four-week period. These domains and single-item questions were taken from the 
Expanded Prostate Cancer Index Composite-26 (EPIC-26) for use in the survey. For 
each domain (urinary, sexual, bowel, vitality) and an additional emotional domain, 
respondents were asked, “Overall, how much of a problem, if any, have urinary (sexual, 
bowel, vitality, emotional) symptoms been for you during the past 4 weeks?” 
Participants indicated their level of burden on a 5-point scale (no problem, very small 
problem, small problem, moderate problem, big problem). For each domain, we split the 
participants into low and high symptom burden groups by placing those participants with 
moderate or big problems into the high symptom burden group and the rest into the low 
symptom burden group. Additionally, we conducted a sensitivity analysis by splitting the 
participants into low and high symptom burden groups using median splits within each 
domain. For some domains (bowel, vitality, emotional), the median score was 1, 
indicating “no problem.” We determined that using the moderate to big problem cutoffs 
(instead of median splits) resulted in a more conservative grouping method. The 
language used in the survey (face validity) captured those who were truly burdened; 
thus, this was the method used for subsequent analyses. 
Information needs 
 We were interested in identifying the primary areas of information need to 
describe topics that could be addressed during clinical encounters with prostate cancer 
survivors, and the extent to which these needs were associated with symptom burden. 
We assessed information needs by asking: “Which areas of prostate cancer-related 
information do you feel that you need more complete information on? Check all that 
apply.” Respondents selected topics from the following list of common survivorship-
related information needs: Information on prostate cancer in general; Causes of 
cancer/prevention of cancer; Diagnosis of cancer; Long-term effects/recovery from 
cancer; Symptoms of cancer; Where to get medical care; Effect of cancer on my spouse 
or partner; Recurrence of prostate cancer; Cancer organizations; Coping with 
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detection; Treatment/cures for cancer; Alternative/home remedies; Effect of cancer on 
my marital relationship; Other (please specify); None.  
Statistical analysis 
 We used descriptive statistics to describe our study population and included the 
following variables: age, race, education level, marital status, income, time since 
diagnosis, treatment type, and low/high domain-specific symptom burden (urinary, 
sexual, bowel, vitality, emotional). We also examined the percentage of patients 
reporting specific cancer survivorship-related information needs to identify the most 
common topics that providers might need to address. Next, we assessed the adjusted 
differences in information need according to domain-specific symptom burden using chi-
square tests with Bonferroni corrections. Last, we used multivariable logistic regression 
to examine the association between high symptom burden and the most common 
reported survivorship-related information need topics (recurrence, relationship effects, 
and long-term effects) adjusting for patient characteristics.  
Research approval was granted by the Michigan Public Health Institute (MPHI) 
and the Michigan Department of Community Health (MDCH) Institutional Review 
Boards, the MPHI privacy officer, and the MDCH Scientific Advisory Panel. All analyses 
were conducted using SPSS™ software version 22. 
Results 
There were 2,499 respondents (Table 1) who were a median of 9 years from 
diagnosis (IQR=7) with a median age of 76 years. Nearly 20% identified themselves as 
non-white. The majority was married (78.4%) and had some level of college education 
(59.8%), with median income ranging from $35,000 - $49,999. Of those who received 
treatment, the majority underwent prostatectomy alone (55.1%). A few respondents 
(12.3%) reported having a recurrence. We found differences in the degree of symptom 
burden across quality of life domains, with the sexual domain having largest group of 
highly burdened men (high sexual burden 44.4%), followed by urinary (14.4%), vitality 
(12.7%), bowel (8.4%), and emotional domains (7.6%).   
 We found that 56% of respondents reported needing more complete cancer 
survivorship information. The leading information needs related to recurrence of 
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effects/recovery from cancer (44.5%) (Table 2). The least information was sought for 
‘other’ (4.9%) and for cancer organizations (5.5%). When stratifying by symptom burden 
level and domain, individuals with high symptom burden compared to low symptom 
burden were more likely to need more information on at least one of the leading topics 
(i.e., recurrence of prostate cancer, effects on spouse/relationship, and long term 
effects/recovery from cancer) regardless of the specific domain (Figure 1). There was a 
strong association between a need for information regarding the identified topics and 
the degree of symptom burden across all five domains: urinary, bowel, sexual, 
emotional, and vitality (all p<0.05). Needing more information about long-term 
effects/recovery from cancer was significantly associated with high symptom burden 
across all domains (p<0.001). Additionally, needing more information about recurrence 
of prostate cancer and effects on spouse/relationship varied across urinary (p=0.007, 
p=0.03), sexual (p=0.004, p< 0.001), vitality (p=0.01, p<0.001), and emotional domains 
(p=0.06, p<0.001). The difference in information needs with regard to prostate cancer 
recurrence and the impact on spouse/relationships was not significant for those with 
high versus low bowel symptoms (p=0.15; p=0.20). 
 We then examined the association between demographic and treatment factors, 
including symptom burden, and information needs (Table 3). Factors associated with 
greater information needs about recurrence of prostate cancer included non-white race 
(Odds Ratio (OR)=1.36; 95% Confidence Interval (CI) 1.00-1.85), having higher income 
(OR=1.72, 95% CI 1.03-2.87), and undergoing a combination of treatments for prostate 
cancer (OR=1.79, 95% CI 1.41-2.28). Factors associated with needing more information 
about prostate cancer’s effects on a spouse/relationship included being 75 years or 
older (OR=0.62, 95% CI 0.40-0.96), non-white (OR=2.46, 95% CI 1.76-3.44), married 
(OR=2.64, 95% CI 1.74-4.02), and having high sexual burden (OR=2.05; 95% CI 1.54-
2.72). Last, we found that being non-white (OR=1.43, 95% CI 1.04-1.96), undergoing a 
combination of treatments for prostate cancer (OR=1.63, 95% CI 1.26-2.12), having a 
recurrence (OR=1.53; 95% CI 1.03-2.28), having high sexual burden (OR=1.60; 95% CI 
1.23-2.07), and having high bowel burden (OR=2.28; 95% CI 1.43-3.63) were all factors 
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Discussion 
 Using a statewide cancer registry of long-term prostate cancer survivors we 
found that unmet information needs are a lasting problem. The leading topics of unmet 
information needs related to recurrence of prostate cancer, effects on 
spouse/relationship, and long term effects/recovery from prostate cancer. Not 
surprisingly, survivors with higher symptom burden compared to those with lower 
symptom burden, regardless of quality of life domain, continue to need more supportive 
information many years after diagnosis, especially with respect to managing the long-
term or late effects of prostate cancer treatment. In addition, we identified sub-groups of 
survivors who were particularly vulnerable to needing more information regarding their 
recovery and survivorship period including non-white prostate cancer survivors and 
those who have undergone a combination of treatments. Health care systems and 
providers should remain vigilant to these unmet information needs long after diagnosis 
and help survivors navigate towards resources to improve their quality of life. Based on 
our findings, outreach efforts should be tailored to survivors at greatest risk of unmet 
information and treatment needs (e.g., those with the greatest symptom burden). 
 Prostate cancer survivors need more long-term information support. Men with 
greater symptom burden may have greater information needs for at least two reasons. 
First, men with greatest symptoms may have greater unmet clinical needs due to lack of 
access to information. Second, men with the greatest symptom burden may not be 
seeking care for all their concerns, perhaps, thinking that nothing could be done to 
alleviate particular symptoms due to lack of information. While providers may be in tune 
with the need for information regarding prostate cancer recurrence, directing survivors 
to resources and/or help with search strategies for other concerns may be beneficial for 
these groups of men. For example, providers could refer survivors to sexual health 
counselors or online resources. 
The 2014 American Cancer Society prostate cancer survivorship care guidelines 
call for reducing such unmet needs. Results reported here identify critical unmet needs 
in addition to particular sub-groups for whom targeted, tailored interventions might be 
warranted rather than a “one size fits all” supportive approach for the entire survivor 
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identifying individuals who may be at a greater risk for reduced quality of life due to their 
symptom burden could be one way to tailor appropriate survivorship care. Automated 
symptom assessment via interactive voice response (IVR) technology is one feasible, 
low cost, and efficient strategy to identify prostate cancer survivors with high symptom 
burden. (27) Using new technologies to monitor outcomes over time and then tailor 
appropriate follow-up care may further improve patient-centered prostate cancer 
survivorship care. 
 This study has several limitations. First, this was a cross-sectional survey so we 
cannot determine causal relationships over time. However, the large sample size and 
extended time since diagnosis both indicate that information needs and symptom 
burden persist long after a cancer diagnosis. Further exploration of how symptom 
burden evolves in long term survivors and the subsequent impacts on changing 
information needs appears warranted, similar to how a changing disease state (i.e., 
cancer recurrence) influenced information needs as discovered in this study. While the 
extent to which survivors in this study were already engaged in symptom management 
was also not known, we continued to find high long-term symptom burden and 
information needs among selected patients indicating further support appears 
warranted. Second, the sample is limited to prostate cancer survivors in the state of 
Michigan. Nonetheless, there is no reason to suspect that this state-based sample 
would diverge from national estimates given the stable and non-trivial rates of side 
effects after prostate cancer treatment across all settings. While we do not have 
prostate cancer pathology for patients in this study to help contextualize our findings, we 
did capture self-reported recurrence and over half of patients were treated with surgery 
indicating the generalizability of our findings to current long-term survivor population. 
Third, our response rate was 38.3% among eligible participants; however, this is 
favorable compared to similar cancer survivorship studies. (28) Fourth, our symptom 
burden measure is based on a dichotomized measure of overall domain-specific 
burden. We used a sensitivity analysis to examine different cutoff values and the 
findings still support the conclusion that survivorship information should be tailored to 
symptom burden. Last, we did not prospectively test whether information needs would 
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improve automated patient-reported assessments, understanding how to tailor 
information to individual patients will be critical to optimizing the quality of survivorship 
care. 
 In conclusion, we found that unmet information needs are a lasting problem 
among long-term prostate cancer survivors. Our findings suggest that non-white race, 
multimodality treatment, recurrence, and high symptom burden were all significant 
correlates of needing more long-term supportive information in specific topic areas. 
Provision of information may acknowledge patient concerns and facilitate primary care 
clinician and specialist efforts to achieve the highest possible long-term quality of life 
after cancer treatment. Future research should assess the effectiveness of tailored 
information support for prostate cancer survivors to determine whether a personalized 
approach can help satisfy long-term information needs and improve overall quality of life 
by promoting self-management and appropriate health care utilization. 
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Figure 1. Information need differences between prostate cancer survivors with low 
versus high domain-specific symptom burden. When stratifying by symptom burden 
level and domain, individuals with high symptom burden compared to low symptom 
burden were more likely to need more information on at least one of the leading topics 
(i.e., recurrence of prostate cancer, effects on spouse/relationship, and long term 
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Table 1. Characteristics of the Michigan Prostate Cancer Survivor Study population (n=2,499) 
 




        ≤64 years 342 (13.8) 
        65 – 74 years 824 (33.3) 




     White 1870 (80.2) 




     Less than high school education 345 (13.9) 
     High school graduate or GED 651 (26.3) 
     Some college to college graduate 989 (40.0) 




     Not married 535 (21.6) 




    ≤ $20,000 316 (13.6) 
     $20,000 – 34,999 637 (27.3) 
     $35,000 – 49,999 461 (19.8) 
     $50,000 – 74,999 418 (17.9) 




     ≤ 5 years 266 (11.1) 
     5 – 9 years 983 (40.9) 
     10 – 14 years 692 (28.8) 




    Prostatectomy 1207 (55.1) 




    No recurrence 2119 (87.7) 




    Low 2077 (85.6) 
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    Low 2214 (91.6) 




    Low 1217 (55.6) 




    Low 1994 (87.3) 




    Low 2075 (92.4) 
    High 170 (7.6) 
Note: a Median age = 76 years, missing values=24; b missing values=169; c missing values=25; d missing 
values=26; e missing values=169; f Median times since diagnosis = 9 years, missing values=25; g missing 
values=310; h missing values = 84; i missing values=72; j missing values = 83; k missing values=311; l 
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Table 2. Information need topics reported by prostate cancer survivors (n=1,397) 
 
Information need topic N % 
Recurrence of Prostate Cancer 776 55.5 
Effects on spouse/relationship 701 50.2 
Long Term Effects/Recovery from Cancer 621 44.5 
Causes of Cancer/Prevention of Cancer 496 35.5 
General Information on Prostate Cancer 478 34.2 
Treatment/Cures for Cancer 451 32.2 
Symptoms of Cancer 327 23.4 
Screening/Testing/Early Detection 270 19.3 
Diagnosis of Cancer 246 17.6 
Coping with Cancer/Dealing with Cancer 234 16.8 
Alternative/Home Remedies 158 11.3 
Paying for Medical Care/Insurance 144 10.3 
Where to Get Medical Care 128 9.1 
Cancer Organizations 77 5.5 
Other 68 4.9 
Note: Multiple answers given; Excludes those who said ‘None’ to 
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Table 3. Factors associated with information needs in long-term prostate cancer survivors (n=2,499) 
 
Information Needs Recurrence  Effects on spouse/relationship Long-term effects/Recovery 
Factors OR1 95% CI p OR 95% CI p OR 95% CI p 
     Age          
        ≤64 years ref   ref   ref   
        65 – 74 years 1.22 0.85 – 1.73 0.28 0.91 0.62 – 1.34 0.64 0.92 0.64 – 1.33 0.67 
        ≥75 years 1.05  0.72 – 1.54 0.80 0.62 0 .40 – 0.96 0.03 0.72 0.48 – 1.08  0.11 
    Race          
       White ref   ref   ref   
       Non-white 1.36 1.00 – 1.85 0.05 2.46 1.76 – 3.44 0.00 1.43 1.04 – 1.96 0.03 
    Marital Status          
       Not married ref   ref   ref   
       Married 0.97 0.72 – 1.33 0.87 2.64 1.74 – 4.02 0.00 1.01 0.72 – 1.40 0.97 
    Income          
       ≤ $20,000 ref   ref   ref   
       $20,000 – 34,999 1.31 0.83 – 2.07 0.25 1.48 0.84 – 2.59 0.17 0.94 0.58 – 1.52 0.80 
       $35,000 – 49,999 1.44 0.89 – 2.33 0.14 1.52 0.85 – 2.72 0.16 1.08 0.65 – 1.80 0.76 
       $50,000 – 74,999 1.40 0.85 – 2.32 0.19 1.15 0.63 – 2.12 0.65 0.99 0.58 – 1.68 0.96 
       ≥ $75,000 1.72 1.03 – 2.87 0.04 1.38 0.74 – 2.56 0.32 1.26 0.73 – 2.16 0.41 
    Treatment type          
       Prostatectomy ref   ref   ref   
       Combination2 1.79 1.41 – 2.28 0.00 1.09 0.82 – 1.44 0.56 1.63 1.26 – 2.12 0.00 
    Disease status          
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       Recurrence 1.17 0.80 – 1.71 0.42 1.23 0.79 – 1.91 0.36 1.53 1.03 – 2.28 0.04 
    Sexual symptom burden          
       Low ref   ref   ref   
       High 1.13 0.88 – 1.44 0.33 2.05 1.54 – 2.72 0.00 1.60 1.23 – 2.07 0.00 
    Bowel symptom burden          
       Low ref   ref   ref   
       High 0.88 0.56 – 1.40 0.60 1.15 0.68 – 1.95 0.61 2.28 1.43 – 3.63 0.001 
Note: 1Adjusted odds ratios. We controlled for the following additional covariates: education, time since diagnosis, and urinary, 
vitality and emotional symptom burden levels. 2Includes a combination of treatments (e.g., radical prostatectomy, external 
















Figure 1. Information need differences between prostate cancer survivors with low versus high domain-specific symptom 
burden. 
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